SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler as Chief Financial Officer (CFO), effective January 29, 2024. Leffler will succeed Myriad CFO Bryan Riggsbee who is retiring. Riggsbee will continue as a strategic advisor through March 31, 2024, to ensure a smooth transition.
Riggsbee joined Myriad in 2014 as CFO. During his nine-year tenure, he has made significant contributions to Myriad's growth strategy and business transformation. In 2020, he served for six months as Myriad's interim CEO, navigating the business and supporting teammates through the height of the pandemic.
"I want to extend my gratitude to Bryan for his leadership and the key role he has played in shaping our business over the past nine years," said Paul J. Diaz, president and CEO, Myriad Genetics. "His vision and financial acumen were critical components to the successful execution of our transformation plan and bringing focus to our three core business units. We thank him for setting the stage for business success and wish him all the best in his next chapter."
Leffler brings to Myriad nearly 20 years of finance experience, across a broad range of healthcare and payer market segments at both public and private equity-backed companies. Leffler has held numerous financial leadership positions and brings expertise in finance transformation, acquisitions and integrations, as well as risk management. In his role as CFO, he is responsible for leading the company's financial team and strategy to support the advancement of Myriad's long-term growth and profitability.
"We are pleased to welcome Scott to Myriad. He is a thoughtful and focused leader who has a proven track record of financial leadership, strategy and execution resulting in notable business growth," said Diaz. "With his strategic vision, analytical curiosity and industry expertise, Scott will play an important role in building on our business foundation to accelerate profitability, financial performance and innovation."
Leffler previously served as the CFO of Clover Health. Prior to Clover Health, he was CFO and Treasurer at Sotera Health. He earned his B.A. in economics and history from Yale University and an M.B.A. from Emory University.
At its third quarter 2023 earnings call on November 6, Myriad updated its 2023 financial guidance and introduced 2024 ...